Furthermore, we found that the type I receptor tyrosine kinase-like orphan receptor (ROR1), a promising target for immunotherapy, was highly expressed in HO8910 CSCs and ID8 cancer stem-like cells and that knockdown of ROR1 via small interfering RNA (siRNA) in CSCs decreased the prophylactic efficacy of CSC vaccination. Here, ROR1 is linked to cancer.